Antibodies from S Africa COVID variant may offer cross-protection

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
Published
South Africa has received its second batch of 80,000 vaccines donated by Johnson & Johnson.
But there are concerns the roll-out is going more slowly than expected while some critics have described it as a clinical trial.
Al Jazeera's Fahmida Miller reports from Johannesburg, South Africa.
- Subscribe to our channel: http://aje.io/AJSubscribe
-
-
- Check our website: https://www.aljazeera.com/
#AlJazeeraEnglish #SouthAfrica #COVID19
Category
South Africa
Tags
johnson & johnson, s africa, south africa, vaccine, covid-19
Show more
Be the first to comment